SCHEMBL12333333

SCHEMBL12333333

CCCc1cc2c(cc1CCC)N(CCOC)C(=O)CC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATAD2 Q6PL18 1/20 0.42
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ BRD4 O60885 1/20 0.37
▸ CHRM1 P11229 4/20 0.37
▸ CHRM2 P08172 2/20 0.37
▸ CHRM4 P08173 2/20 0.37
▸ CHRM5 P08912 2/20 0.37
▸ DRD2 P14416 2/20 0.37
▸ CHRM3 P20309 2/20 0.37
▸ DRD4 P21917 2/20 0.37
▸ DRD3 P35462 2/20 0.37
▸ HPGD P15428 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP11B1 P15538 1/20 0.35
▸ CYP11B2 P19099 1/20 0.35
▸ GRIN1 Q05586 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14641644 0.79 ATAD2 (0.41) ATAD2HDAC1HDAC8HDAC6BRD4
SCHEMBL12107604 0.76 ATAD2 (0.39) ATAD2BRD4CHRM1HPGDHTT
SCHEMBL18421351 0.74 ATAD2 (0.72) ATAD2HDAC1HDAC8HDAC6BRD4
SCHEMBL18055285 0.72 ATAD2 (0.36) ATAD2BRD4CHRM1CHRM2CHRM4
SCHEMBL3629805 0.72 HTT (0.50) HPGDHTTSMN1; SMN2CYP1A2ALDH1A1
SCHEMBL18421420 0.70 GRIN1 (0.51) ATAD2DRD2DRD4DRD3HTT
SCHEMBL12333092 0.69 REN (0.50) CHRM1CHRM5DRD2CHRM3HTT
SCHEMBL12110145 0.69 CHRM1 (0.35) ATAD2BRD4CHRM1CHRM2CHRM4
SCHEMBL12110391 0.69 GRIN1 (0.34) ATAD2BRD4CHRM1CHRM2CHRM4
SCHEMBL3310122 0.69 BRD4 (0.47) ATAD2HDAC1HDAC6BRD4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011111817-A1 BENZAZEPINE COMPOUND アステラス製薬株式会社 (JP) 2011-09-15 — — WO disclosed
Send feedback